FDA review of prescription fluoride draws support from health providers and the public
Prescription-strength fluoride products, commonly used to prevent tooth decay in patients at high risk, are now under regulatory review by the U.S. Food and Drug Administration (FDA). Despite decades of use and support from dental professionals, the FDA has begun re-examining these fluoride formulations due to technicalities in how they are classified and approved—raising concerns among healthcare providers and advocates about the future availability of an essential tool in oral health care.For numerous dental professionals, prescribing fluoride has been an essential aspect of treating those prone to cavity formation, such as young patients, the elderly, and individuals with health issues…